Drug & medication recalls Moderate risk

Acyclovir sodium recalled over sterility concerns

Recall date
February 5, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Fresenius Kabi Compounding, LLC recalls acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use B…
Recall number
D-0333-2026
FDA classification
Class II
Brand / firm
Fresenius Kabi Compounding, LLC
Sold / distributed
US Nationwide.

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56

Get recall alerts

Free email alert whenever Fresenius Kabi Compounding, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Fresenius Kabi Compounding, LLC